In conclusion, SOCS-1 is commonly methylated in pancreatic adenocarcinoma and loss of SOCS-1 in pancreatic cancer is moderately associated with increased IL-6-mediated growth. This evidence concerns the gene IL6 and pancreatic neoplasm.